Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
J. Kevin Buchi is a businessperson who has been at the head of 5 different companies is on the board of ChemGenex Pharmaceuticals Pty Ltd. and 4 other companies. In his past career he occupied the position of Chairman at Dicerna Pharmaceuticals, Inc., President, Chief Executive Officer & Director at TetraLogic Pharmaceuticals Corp., Vice President-Global Branded Products at Teva Pharmaceutical Industries Ltd. and Chief Executive Officer & Director at Cephalon, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Chief Executive Officer & Director at BioSpecifics Technologies Corp. and Director at Impax Laboratories LLC.

J. Kevin Buchi received an undergraduate degree from Cornell University and a graduate degree from Kellogg School of Management.

Current positions of J. Kevin Buchi 
NameTitle Since
Amneal Pharmaceuticals, Inc.
Independent Director 2018
Ampio Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Director 2021
Benitec Biopharma Inc.
(Biotechnology & Medical Research)
Independent Non-Executive Director 2013
ChemGenex Pharmaceuticals Pty Ltd. Director 2011
Benitec Biopharma Pty Ltd. Independent Non-Executive Director 2013

Holdings of J. Kevin Buchi 
Amneal Pharmaceuticals, Inc. (AMRX)
70,0850.047%335,707 USD
Benitec Biopharma Inc. (BNTC)
(Biotechnology & Medical Research)
4,8270.059%12,647 USD
ZIOPHARM Oncology, Inc. (ZIOP)
(Biotechnology & Medical Research)
4,1670.0019%4,542 USD
Ampio Pharmaceuticals, Inc. (AMPE)
(Biotechnology & Medical Research)
00.0000%0 USD

J. Kevin Buchi: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
01/17ELON MUSK : Top Energy News of the Day
More news

© 2022 People and Ownership :   
J. Kevin Buchi : Connections